Log In
Print this Print this

AzaSite Plus (ISV-502)

  Manage Alerts
Collapse Summary General Information
Company Sun Pharmaceutical Industries Ltd.
DescriptionCombination of azithromycin antibiotic and dexamethasone corticosteroid in InSite's DuraSite ophthalmic drug delivery system
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat blepharitis
Regulatory Designation U.S. - Special Protocol Assessment (Treat blepharitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today